• Corpus ID: 249957507

OTT_A_195796 6323..6335

  title={OTT\_A\_195796 6323..6335},
  author={Xihua Wei and Xuelian Gu and Min Ma and Chunxiang Lou},
Xihua Wei Xuelian Gu Min Ma Chunxiang Lou 1Department of Dermatology, 2Department of Oncology, 3Department of Gynecology and Obstetrics, the Third Hospital of Ji’nan, Jinan, Shandong 250132, People’s Republic of China Objective: This research aimed to investigate the role and mechanism of long noncoding RNA (lncRNA) HCP5 in skin cutaneous melanoma (SKCM). Materials and methods: Survival analysis was performed using The Cancer Genome Atlas (TCGA)-SKCM data and SKCM patients’ clinical data… 

Figures and Tables from this paper



LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.

In vitro experiments showed that HCP5 promoted proliferation of cervical cancer cells, which was reversed by microRNA-15a knockdown, and overexpression of microRNAs could remarkably inhibited MACC1 expression.

LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge

It is revealed that HCP5 is a tumour regulator in the development of FTC and that it may contribute to improvement of FTC diagnosis and therapy.

RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer.

It is for the first time found that RARRES3 was able to suppress the metastasis of CRC both in vitro and in vivo via suppression of MTDH so as to regulate EMT.

Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.

Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells.

It is demonstrated that the HCP5-microRNA-139- Runt-related transcription factor 1 feedback loop plays a pivotal role in regulating the malignant behavior of glioma cells, which may provide a potential therapeutic strategy for treating gliomas.

The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma

This study provides novel insights into the molecular heterogeneity of cutaneous melanoma and also shows potentially important implications of lncRNAs for prognosis and therapy for cutaneously melanoma.

Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.

Investigation of the expression of retinoic acid receptor responder 3 in paraffin-embedded tissues of hepatocellular carcinoma and cholangiocarcinoma suggests that altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract.

Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC

MiR-126, DACH1, GRM8, MET, GSR, and HCP5 were implicated in the lymph node metastasis process of SCLC and were correlated with survival of SclC patients.

The emerging role of long non‐coding RNAs in cutaneous melanoma

Recent data highlighting the importance of lncRNAs in the biology of melanoma and their potential utility as biomarkers and therapeutic targets are summarized.